Influenza vaccination in tropical and subtropical areas

The Lancet Respiratory Medicine

Volumn 5, Issue 12, 2017, Pages 920-922

  Xu, Cuiling ^a,b   Thompson, Mark G ^c   Cowling, Benjamin J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGING; ANTIBODY RESPONSE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DEATH; DISEASE ACTIVITY; DISEASE BURDEN; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG FORMULATION; EPIDEMIC; EVIDENCE BASED PRACTICE; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; IMMUNITY; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; NORTHERN HEMISPHERE; NOTE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; TROPIC CLIMATE; TROPICS; SEASON;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; SEASONS; TROPICAL CLIMATE;

EID: 85035053274     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(17)30377-6     Document Type: Note

References (12)

1. Haq, K, McElhaney, JE, Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol 29 (2014), 38–42.
2. Dominguez, A, Godoy, P, Torner, N, The effectiveness of influenza vaccination in different groups. Expert Rev Vaccines 15 (2016), 751–764.
3. Bloom-Feshbach, K, Alonso, WJ, Charu, V, et al. Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One, 8, 2013, e54445.
4. Vashishtha, VM, Kalra, A, Choudhury, P, Influenza vaccination in India: position paper of Indian Academy of Pediatrics, 2013. Indian Pediatr 50 (2013), 867–874.
5. Yu, H, Alonso, WJ, Feng, L, et al. Characterization of regional influenza seasonality patterns in China and implications for vaccination strategies: spatio-temporal modeling of surveillance data. PLoS Med, 10, 2013, e1001552.
6. Center for Health Protection. Scientific committee recommends priority groups to receive southern hemisphere influenza vaccine. http://www.chp.gov.hk/en/content/568/38938.html, March 20, 2015 (accessed Sept 7, 2017).
7. Pan American Health Organization. Final report of the XXIII Technical Advisory Group (TAG) meeting on vaccine-preventable diseases of the Pan American Health Organization, held in Varadero, Cuba. http://www.paho.org/hq/index.php?option=com_docman&task=doc_download&gid=31233&Itemid=270&lang=en, July 1–3, 2015 (accessed Sept 7, 2017).
8. Kannan, S, Kossenkov, A, Kurupati, RK, et al. A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged. Aging (Albany NY) 7 (2015), 1077–1085.
9. Ljungman, P, Nahi, H, Linde, A, Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol 130 (2005), 96–98.
10. Skowronski, DM, Tweed, SA, De Serres, G, Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?. J Infect Dis 197 (2008), 490–502.
11. McElhaney, JE, Xie, D, Hager, WD, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176 (2006), 6333–6339.
12. Belongia, EA, Skowronski, DM, McLean, HQ, Chambers, C, Sundaram, ME, De Serres, G, Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines 16 (2017), 1–14.